CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable, Related Parties
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Accounts Receivable, Related Parties of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-07-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2023-07-28
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2022-03-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2022 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2021 was -$127.00K, a 109.44% decline from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2020 was $1.35M, a 8.68% decline from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2019 was $1.47M.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-07-28 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-07-28 | $0.00 10-K · filed 2023-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-07-28 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-07-28 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | $0.00 derived: sum of 3 quarters · filed 2023-07-28 | $0.00 derived: sum of 4 quarters · filed 2023-07-28 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | -$127.00K 10-K · filed 2023-03-22 | $127.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | -$127.00K 10-Q · filed 2022-11-03 | $2.29M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$127.00K 10-Q · filed 2022-08-09 | $2.29M derived: sum of 3 quarters · filed 2022-08-09 | $1.94M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$127.00K 10-Q · filed 2022-05-04 | $2.29M derived: sum of 2 quarters · filed 2022-05-04 | $1.94M derived: sum of 3 quarters · filed 2022-05-04 | $1.67M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.07M derived: sum of 2 quarters · filed 2022-02-24 | $1.79M derived: sum of 3 quarters · filed 2022-02-24 | $1.35M 10-K · filed 2022-02-24 | -$1.35M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$351.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$626.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.07M 10-Q · filed 2021-11-09 | -$1.04M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$723.00K 10-Q · filed 2021-07-29 | -$689.00K derived: sum of 3 quarters · filed 2021-07-29 | -$1.11M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | -$448.00K 10-Q · filed 2021-04-30 | -$414.00K derived: sum of 2 quarters · filed 2021-04-30 | -$831.00K derived: sum of 3 quarters · filed 2021-04-30 | ||
| 2019-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$383.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.47M 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.44M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $1.86M 10-Q · filed 2020-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |